In particular, several studies reported that IL-33 and ST2 are implicated as potent modulators of the TME promoting immune cells recruitment and tumor malignancy in different types of cancer, including breast cancer, hepatocellular carcinoma, gastric cancer, and CRC31,57,58. The gene discussed is IL33; the disease is neoplasm.